Application of Mesenchymal Stem Cell-Derived Extracellular Vesicles for Stroke: Biodistribution and MicroRNA Study
Overview
Authors
Affiliations
Mesenchymal stem cells (MSCs) exert their therapeutic capability through a variety of bioactive substances, including trophic factors, microRNAs, and extracellular vesicles (EVs) in infarcted tissues. We therefore hypothesized that MSC-derived EVs (MSC-EVs) possess therapeutic molecules similar to MSCs. Moreover, given their nature as nanosized and lipid-shielded particles, the intravenous infusion of MSC-EVs would be advantageous over MSCs as a safer therapeutic approach. In this study, we investigated the biodistribution, therapeutic efficacy, and mode of action of MSC-EVs in a rat stroke model. MSC-EVs successfully stimulated neurogenesis and angiogenesis in vivo. When compared to the MSC-treated group, rats treated with MSC-EVs exhibited greater behavioral improvements than the control group (p < 0.05). Our biodistribution study using fluorescence-labeled MSC-EVs and MSCs demonstrated that the amounts of MSC-EVs in the infarcted hemisphere increased in a dose-dependent manner, and were rarely found in the lung and liver. In addition, MSC-EVs were highly inclusive of various proteins and microRNAs (miRNAs) associated with neurogenesis and/or angiogenesis compared to fibro-EVs. We further analyzed those miRNAs and found that miRNA-184 and miRNA-210 were essential for promoting neurogenesis and angiogenesis of MSC-EVs, respectively. MSC-EVs represent an ideal alternative to MSCs for stroke treatment, with similar medicinal capacity but an improved safety profile that overcomes cell-associated limitations in stem cell therapy.
The Role of Extracellular Vesicles in Aging and Age-Related Disorders.
Ganesh B, Padinjarathil H, Rajendran R, Ramani P, Gangadaran P, Ahn B Antioxidants (Basel). 2025; 14(2).
PMID: 40002364 PMC: 11851802. DOI: 10.3390/antiox14020177.
Quan J, Liu Q, Li P, Yang Z, Zhang Y, Zhao F Stem Cell Res Ther. 2025; 16(1):76.
PMID: 39985030 PMC: 11846194. DOI: 10.1186/s13287-025-04160-5.
Current Development of Mesenchymal Stem Cell-Derived Extracellular Vesicles.
Zheng B, Wang X, Guo M, Tzeng C Cell Transplant. 2025; 34:9636897241297623.
PMID: 39874070 PMC: 11775985. DOI: 10.1177/09636897241297623.
Lee J, Var S, Chen D, Natera-Rodriguez D, Hassanipour M, West M bioRxiv. 2025; .
PMID: 39829810 PMC: 11741374. DOI: 10.1101/2025.01.07.631793.
Transforming Medicine: Cutting-Edge Applications of Nanoscale Materials in Drug Delivery.
Tenchov R, Hughes K, Ganesan M, Iyer K, Ralhan K, Lotti Diaz L ACS Nano. 2025; 19(4):4011-4038.
PMID: 39823199 PMC: 11803921. DOI: 10.1021/acsnano.4c09566.